CD4 and multiple sclerosis: By comparing CSF immune cells from multiple sclerosis relapse with those collected during therapeutic very late antigen-4 blockade, researchers identified immune subsets from various lineages, including CNS border-associated macrophages, CD8 and CD4 TRM cells, and tissue-resident NK cells.